NCT03222206View on ClinicalTrials.gov

The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

February 22, 2019

Study Completion Date

February 22, 2019

Conditions
Non Alcoholic Fatty LiverOsteo Arthritis
Interventions
DRUG

Salsalate

"1. Medicate salsalate 2g/day after run-in period~2. Check side effect after 1 month and Control dosage (2g/day or 3g/day)~3. Check side effect after 2 month"

OTHER

Placebo

"1. Medicate placebo 2g/day after run-in period~2. Check side effect after 1 month and Control dosage (2g/day or 3g/day)~3. Check side effect after 2 month"

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Kuhnil Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea University Guro Hospital

OTHER

NCT03222206 - The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter